Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
NeoGenomics, Inc. (NEO) had Cash Flow from Financial Activities of $-12.58M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$201.66M |
|
$2.24M |
|
$109.78M |
|
$91.88M |
|
$211.43M |
|
$-9.77M |
|
$11.60M |
|
$1.83M |
|
$1.83M |
|
$2.24M |
|
$2.24M |
|
$2.24M |
|
$2.24M |
|
$-9.77M |
|
$7.21M |
|
129.63M |
|
130.83M |
|
$0.02 |
|
$0.02 |
|
| Balance Sheet Financials | |
$381.48M |
|
$80.94M |
|
$970.76M |
|
$1.35B |
|
$105.88M |
|
$378.27M |
|
$460.63M |
|
$566.51M |
|
$785.73M |
|
$-9.52M |
|
$785.73M |
|
127.92M |
|
| Cash Flow Statement Financials | |
$11.82M |
|
$-13.32M |
|
|
Cash Flow from Financial Activities |
$-12.58M |
$159.62M |
|
$145.54M |
|
$-14.08M |
|
$17.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.60 |
|
-- |
|
-- |
|
0.33 |
|
0.48 |
|
45.56% |
|
-4.85% |
|
-4.85% |
|
-- |
|
0.91% |
|
1.11% |
|
$-1.40M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
4.05 |
|
1.15 |
|
78.28 |
|
0.28% |
|
-23.50% |
|
0.17% |
|
0.19% |
|
$6.14 |
|
$-0.01 |
|
$0.09 |
|